Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock Voting | Additional Paid In Capital | Accumulated Other Comprehensive Income (Loss) | Treasury Stock | Retained Earnings |
Beginning balance, common stock (in shares) at Mar. 31, 2021 | | 124,197,974 | | | | |
Beginning balance at Mar. 31, 2021 | $ 2,005,779 | $ 124 | $ 2,955,400 | $ (1,940) | $ (1,322,496) | $ 374,691 |
Beginning balance, treasury stock (in shares) at Mar. 31, 2021 | | | | | 50,446,359 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Net income | 44,280 | | | | | 44,280 |
Unrealized net investment gains | (5) | | | (5) | | |
Unrealized net gain (loss) on derivative financial instruments | 99 | | | 99 | | |
Cumulative translation adjustments | 51 | | | 51 | | |
Issuance of common stock pursuant to vesting of restricted stock units (in shares) | | 1,688,026 | | | | |
Issuance of common stock pursuant to vesting of restricted stock units | 2 | $ 2 | | | | |
Stock-based compensation expense for restricted stock units granted to employees | 41,389 | | 41,389 | | | |
Issuance of common stock under employee stock purchase plan (in shares) | | 251,308 | | | | |
Issuance of common stock under employee stock purchase plan | 6,890 | | 6,890 | | | |
Repurchase of treasury stock (in shares) | | | | | 1,862,403 | |
Repurchase of treasury stock | (50,898) | | | | $ (50,898) | |
Ending balance, common stock (in shares) at Dec. 31, 2021 | | 126,137,308 | | | | |
Ending balance at Dec. 31, 2021 | 2,047,587 | $ 126 | 3,003,679 | (1,795) | $ (1,373,394) | 418,971 |
Ending balance, treasury stock (in shares) at Dec. 31, 2021 | | | | | 52,308,762 | |
Beginning balance, common stock (in shares) at Sep. 30, 2021 | | 126,108,858 | | | | |
Beginning balance at Sep. 30, 2021 | 1,999,004 | $ 126 | 2,991,704 | (1,931) | $ (1,362,141) | 371,246 |
Beginning balance, treasury stock (in shares) at Sep. 30, 2021 | | | | | 51,891,197 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Net income | 47,725 | | | | | 47,725 |
Unrealized net investment gains | 0 | | | | | |
Unrealized net gain (loss) on derivative financial instruments | 52 | | | 52 | | |
Cumulative translation adjustments | 84 | | | 84 | | |
Issuance of common stock pursuant to vesting of restricted stock units (in shares) | | 28,450 | | | | |
Issuance of common stock pursuant to vesting of restricted stock units | 0 | $ 0 | | | | |
Stock-based compensation expense for restricted stock units granted to employees | 11,975 | | 11,975 | | | |
Repurchase of treasury stock (in shares) | | | | | 417,565 | |
Repurchase of treasury stock | (11,253) | | | | $ (11,253) | |
Ending balance, common stock (in shares) at Dec. 31, 2021 | | 126,137,308 | | | | |
Ending balance at Dec. 31, 2021 | $ 2,047,587 | $ 126 | 3,003,679 | (1,795) | $ (1,373,394) | 418,971 |
Ending balance, treasury stock (in shares) at Dec. 31, 2021 | | | | | 52,308,762 | |
Beginning balance, common stock (in shares) at Mar. 31, 2022 | 74,102,293 | 126,425,383 | | | | |
Beginning balance at Mar. 31, 2022 | $ 2,060,395 | $ 126 | 3,023,403 | 141 | $ (1,373,840) | 410,565 |
Beginning balance, treasury stock (in shares) at Mar. 31, 2022 | 52,323,090 | | | | 52,323,090 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Net income | $ 62,869 | | | | | 62,869 |
Unrealized net investment gains | 14 | | | 14 | | |
Unrealized net gain (loss) on derivative financial instruments | (61) | | | (61) | | |
Cumulative translation adjustments | (447) | | | (447) | | |
Issuance of common stock pursuant to vesting of restricted stock units (in shares) | | 1,758,002 | | | | |
Issuance of common stock pursuant to vesting of restricted stock units | 2 | $ 2 | | | | |
Stock-based compensation expense for restricted stock units granted to employees | 45,068 | | 45,068 | | | |
Issuance of common stock under employee stock purchase plan (in shares) | | 206,029 | | | | |
Issuance of common stock under employee stock purchase plan | 6,539 | | 6,539 | | | |
Repurchase of treasury stock (in shares) | | | | | 5,104,980 | |
Repurchase of treasury stock | $ (169,226) | | 2,856 | | $ (172,082) | |
Ending balance, common stock (in shares) at Dec. 31, 2022 | 70,961,344 | 128,389,414 | | | | |
Ending balance at Dec. 31, 2022 | $ 2,005,153 | $ 128 | 3,077,866 | (353) | $ (1,545,922) | 473,434 |
Ending balance, treasury stock (in shares) at Dec. 31, 2022 | 57,428,070 | | | | 57,428,070 | |
Beginning balance, common stock (in shares) at Sep. 30, 2022 | | 128,373,156 | | | | |
Beginning balance at Sep. 30, 2022 | $ 1,937,646 | $ 128 | 3,015,644 | (1,056) | $ (1,497,886) | 420,816 |
Beginning balance, treasury stock (in shares) at Sep. 30, 2022 | | | | | 56,129,506 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Net income | 52,618 | | | | | 52,618 |
Unrealized net investment gains | 25 | | | 25 | | |
Unrealized net gain (loss) on derivative financial instruments | 564 | | | 564 | | |
Cumulative translation adjustments | 114 | | | 114 | | |
Issuance of common stock pursuant to vesting of restricted stock units (in shares) | | 16,258 | | | | |
Issuance of common stock pursuant to vesting of restricted stock units | 0 | | | | | |
Stock-based compensation expense for restricted stock units granted to employees | 14,366 | | 14,366 | | | |
Repurchase of treasury stock (in shares) | | | | | 1,298,564 | |
Repurchase of treasury stock | $ (180) | | 47,856 | | $ (48,036) | |
Ending balance, common stock (in shares) at Dec. 31, 2022 | 70,961,344 | 128,389,414 | | | | |
Ending balance at Dec. 31, 2022 | $ 2,005,153 | $ 128 | $ 3,077,866 | $ (353) | $ (1,545,922) | $ 473,434 |
Ending balance, treasury stock (in shares) at Dec. 31, 2022 | 57,428,070 | | | | 57,428,070 | |